Australia vs Belgium: Proportion of isolates with decreased susceptibility or resistance
Australia
0.01
in 2020
Belgium
0.6
in 2020
Australia rank
12th
Belgium rank
10th
Proportion of isolates with decreased susceptibility or resistance over time
- Australia
- Belgium
How they compare
Belgium currently reports 0.6 against 0.01 in Australia, a difference of 0.59.
That makes Belgium's figure about 60.0 times Australia's.
The two have swapped places 1 time across 10 shared years of data; in 2009 it was Australia ahead.
Australia ranks 12th and Belgium ranks 10th of 52 countries.
Across the 3 decades both report, Australia averaged higher in 2 and Belgium in 1.
Head to head by decade
| Decade | Australia | Belgium | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0317 | 0 | 0.0317 | Australia |
| 2010s | 0.376 | 0 | 0.376 | Australia |
| 2020s | 0.01 | 0.6 | 0.59 | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Australia or Belgium?
- Belgium, at 0.6 against 0.01 in Australia as of 2020.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Australia and Belgium?
- 0.59, with Belgium ahead.
- How many years of comparable data are there for Australia and Belgium?
- 10 years are reported by both, from 2009 to 2020.
- How do Australia and Belgium rank globally for proportion of isolates with decreased susceptibility or resistance?
- Australia ranks 12th and Belgium ranks 10th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.